S&P 500 7,370.81 â–ŧ 101.98 (-1.36%) DOW 51,692.85 â–ŧ 19.86 (-0.04%) NASDAQ 25,611.30 â–ŧ 555.30 (-2.12%) US Markets Closed â€ĸ 05:27 PM ET

NTHI

NeOnc Technologies Holdings, Inc.

Price Chart
Latest Quote

$5.11

-0.16 (-3.04%)
Current Price
Previous Close $5.27
Open $5.19
Day High $5.32
Day Low $4.94
Volume 159,293
Fetched: 2026-06-23T08:46:51
Stock Information
Shares Outstanding 25.93M
Total Debt $346K
Cash Equivalents $139K
Net Income $-38.64M
Sector Healthcare
Industry Biotechnology
Market Cap $126.55M
EPS (TTM) $-1.80
Exchange NGM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$129.57M
Income$-38.64M
Book/sh$-0.55
Cash/sh$0.01
Employees5
Financial Ratios
Quick Ratio0.02
Current Ratio0.13
Returns & Margins
ROA-354.61%
Ownership
Insider Ownership56.68%
Institutional Ownership11.25%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-6.48
P/B-8.91
Analyst Data
Recommendationnone
Target Price$16.00
Technical Indicators
SMA20$4.72
SMA50$4.96
SMA200$8.13
RSI54.56
ATR0.5694
Shares Float7.99M
Short Float2.29%
Short Ratio2.70
Rel Volume0.69
Performance History
Week+8.20%
Month-8.96%
Quarter-38.07%
6 Months-30.48%
YTD-45.05%
Year+14.69%
10 Years-59.70%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-23 $4.88 77,096
2026-06-22 $5.11 159,900
2026-06-18 $5.27 373,800
2026-06-17 $4.81 105,700
2026-06-16 $5.18 223,200
2026-06-15 $4.51 89,600
2026-06-12 $4.75 641,000
2026-06-11 $4.50 26,400
2026-06-10 $4.55 42,300
2026-06-09 $4.42 27,300
2026-06-08 $4.49 66,600
2026-06-05 $4.42 52,200
2026-06-04 $4.57 35,400
2026-06-03 $4.35 49,300
2026-06-02 $4.58 69,900
2026-06-01 $4.54 31,600
2026-05-29 $4.64 27,900
2026-05-28 $4.79 54,500
2026-05-27 $4.84 66,300
2026-05-26 $5.14 12,300
About NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $39,990 $83,000 $70,462 $20,000
Operating Revenue $39,990 $83,000 $70,462 $20,000
Expenses
Interest Expense $2,504,567 $2,557,055 $2,723,396 $200,153
Total Expenses $58,209,188 $7,225,522 $8,168,131 $2,857,604
Other Income Expense $-689,543 $-2,069,923 $-4,100,000 $-9,000
Net Non Operating Interest Income Expense $-3,287,469 $-2,686,019 $-2,723,396 $-200,153
Total Other Finance Cost $1,110,484 $145,097 - -
Interest Expense Non Operating $2,504,567 $2,557,055 $2,723,396 $200,153
Operating Expense $58,209,188 $7,225,522 $8,168,131 $2,857,604
Other Operating Expenses $11,716,559 $500,000 $3,237,773 -
General And Administrative Expense $42,854,372 $3,680,283 $3,396,244 $1,694,274
Other Non Operating Income Expenses - - - $-9,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Net Interest Income $-3,287,469 $-2,686,019 $-2,723,396 $-200,153
Interest Income $327,582 $16,133 $0 -
Normalized Income $-61,456,667 $-9,828,541 $-10,821,065 $-3,046,757
Net Income From Continuing And Discontinued Operation $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Total Operating Income As Reported $-58,240,445 $-7,142,522 $-12,197,669 $-2,837,604
Net Income Common Stockholders $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Net Income $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Net Income Including Noncontrolling Interests $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Net Income Continuous Operations $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Pretax Income $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Special Income Charges $0 $-2,069,923 $-4,100,000 $0
Interest Income Non Operating $327,582 $16,133 $0 -
Operating Income $-58,169,198 $-7,142,522 $-8,097,669 $-2,837,604
Per Share
Diluted EPS $-3.20 $-0.63 $-0.80 $-0.16
Basic EPS $-3.20 $-0.63 $-0.80 $-0.16
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-58,915,639 $-7,025,541 $-8,097,669 $-2,846,604
Total Unusual Items $-689,543 $-2,069,923 $-4,100,000 $0
Total Unusual Items Excluding Goodwill $-689,543 $-2,069,923 $-4,100,000 $0
Reconciled Depreciation $36,461 $245,945 $0 -
EBITDA (Bullshit earnings) $-59,605,182 $-9,095,464 $-12,197,669 $-2,846,604
EBIT $-59,641,643 $-9,341,409 $-12,197,669 $-2,846,604
Diluted Average Shares $19,398,776 $18,745,865 $18,745,865 $18,745,865
Basic Average Shares $19,398,776 $18,745,865 $18,745,865 $18,745,865
Diluted NI Availto Com Stockholders $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Gain On Sale Of Security $-689,543 - - -
Research And Development $3,638,257 $3,045,239 $1,534,114 $1,163,330
Selling General And Administration $42,854,372 $3,680,283 $3,396,244 $1,694,274
Other Gand A $7,299,313 $3,680,283 $3,396,244 $1,694,274
Salaries And Wages $35,555,059 $0 - -
Other Special Charges - $2,069,923 $4,100,000 -
Fetched: 2026-06-15
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-18,007,729 $-5,504,961 $-13,988,253 $-1,575,411
Total Assets $2,823,634 $3,417,241 $1,265,376 $728,682
Total Non Current Assets $1,434,923 $1,222,038 $0 $0
Other Non Current Assets $47,177 - - -
Financial Assets $526,701 $1,198,512 - -
Goodwill And Other Intangible Assets $500,000 $0 - -
Current Assets $1,388,711 $2,195,203 $1,265,376 $728,682
Hedging Assets Current $671,804 $671,804 $0 -
Current Deferred Assets $75,082 $1,071,947 $970,582 $0
Prepaid Assets $583,096 $386,559 $262,932 $95,384
Cash Cash Equivalents And Short Term Investments $58,729 $64,893 $31,862 $633,298
Cash And Cash Equivalents $58,729 $64,893 $31,862 $633,298
Cash Financial $58,729 $64,893 $31,862 $633,298
Debt
Net Debt $5,893,337 - $6,573,595 -
Total Debt $6,313,879 $24,722 $6,605,457 $50,000
Long Term Debt And Capital Lease Obligation $290,682 $0 - -
Current Debt And Capital Lease Obligation $6,023,197 $24,722 $6,605,457 $50,000
Current Debt $5,952,066 - $6,605,457 $50,000
Other Current Borrowings $5,952,066 - $6,555,457 -
Liabilities
Total Liabilities Net Minority Interest $20,331,363 $8,922,202 $15,253,629 $2,304,093
Total Non Current Liabilities Net Minority Interest $290,682 $0 $0 $0
Current Liabilities $20,040,681 $8,922,202 $15,253,629 $2,304,093
Payables And Accrued Expenses $13,762,385 $8,162,606 $7,556,929 $1,341,593
Payables $12,005,244 $8,162,606 $7,556,929 $1,341,593
Other Payable $4,892,059 $4,641,250 $4,600,000 -
Accounts Payable $7,113,185 $3,521,356 $2,956,929 $1,341,593
Current Notes Payable - $0 $50,000 $50,000
Current Deferred Liabilities - - $0 $500,000
Equity
Common Stock Equity $-17,507,729 $-5,504,961 $-13,988,253 $-1,575,411
Total Equity Gross Minority Interest $-17,507,729 $-5,504,961 $-13,988,253 $-1,575,411
Stockholders Equity $-17,507,729 $-5,504,961 $-13,988,253 $-1,575,411
Retained Earnings $-112,754,655 $-50,608,445 $-38,709,981 $-23,788,916
Preferred Stock Equity - - - $3,030
Other
Treasury Shares Number $302,766 - - -
Ordinary Shares Number $21,687,922 $18,745,865 $18,745,865 $18,745,865
Share Issued $21,990,688 $18,745,865 $18,745,865 $18,745,865
Tangible Book Value $-18,007,729 $-5,504,961 $-13,988,253 $-1,575,411
Invested Capital $-11,555,663 $-5,504,961 $-7,382,796 $-1,525,411
Working Capital $-18,651,970 $-6,726,999 $-13,988,253 $-1,575,411
Capital Lease Obligations $361,813 $24,722 $0 -
Total Capitalization $-17,507,729 $-5,504,961 $-13,988,253 $-1,575,411
Treasury Stock $2,706,307 $0 - -
Additional Paid In Capital $97,951,035 $45,101,675 $24,720,072 $22,212,455
Capital Stock $2,198 $1,809 $1,656 $1,050
Common Stock $2,198 $1,809 $1,656 $1,050
Preferred Stock $0 $0 $0 $0
Long Term Capital Lease Obligation $290,682 $0 - -
Current Capital Lease Obligation $71,131 $24,722 $0 -
Pensionand Other Post Retirement Benefit Plans Current $255,099 $734,874 $1,091,243 $412,500
Current Accrued Expenses $1,757,141 $0 - -
Net PPE $361,045 $23,526 $0 -
Gross PPE $361,045 $23,526 $0 -
Other Properties $361,045 $23,526 - -
Current Deferred Revenue - - $0 $500,000
Dueto Related Parties Current - - - $0
Fetched: 2026-06-15
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-20,863,948 $-4,213,916 $-1,880,012 $-881,736
Operating Activities
Operating Cash Flow $-20,363,948 $-4,213,916 $-1,880,012 $-881,736
Cash Flow From Continuing Operating Activities $-20,363,949 $-4,213,916 $-1,880,012 $-881,736
Operating Gains Losses $689,543 $2,069,923 - -
Investing Activities
Capital Expenditure $-500,000 - - -
Investing Cash Flow $-500,000 $0 - -
Cash Flow From Continuing Investing Activities $-500,000 $0 - -
Financing Activities
Issuance Of Capital Stock $17,157,784 $4,615,789 $450 $2,400,000
Financing Cash Flow $20,857,784 $4,246,947 $1,278,576 $1,490,000
Cash Flow From Continuing Financing Activities $20,857,784 $4,246,947 $1,278,576 $1,490,000
Net Common Stock Issuance $17,157,784 $4,615,789 $450 $2,400,000
Common Stock Issuance $17,157,784 $4,615,789 $450 $2,400,000
Net Other Financing Charges - $-469,793 $-94,569 $-700,000
Other
Repayment Of Debt $-600,000 $-791,077 $-2,135,277 $-335,000
Issuance Of Debt $4,300,000 $892,028 $3,507,972 $125,000
End Cash Position $58,729 $64,893 $31,862 $633,298
Beginning Cash Position $64,893 $31,862 $633,298 $25,034
Changes In Cash $-6,164 $33,031 $-601,436 $608,264
Net Issuance Payments Of Debt $3,700,000 $100,951 $1,372,695 $-210,000
Net Short Term Debt Issuance $-300,000 $100,951 $1,372,695 $-210,000
Short Term Debt Payments $-600,000 $-791,077 $-2,135,277 $-335,000
Short Term Debt Issuance $300,000 $892,028 $3,507,972 $125,000
Net Long Term Debt Issuance $4,000,000 $0 - -
Long Term Debt Issuance $4,000,000 $0 - -
Net Intangibles Purchase And Sale $-500,000 $0 - -
Purchase Of Intangibles $-500,000 $0 - -
Change In Working Capital $2,138,648 $1,486,339 $1,713,758 $666,221
Change In Other Current Liabilities $-12,167 $-244,748 $0 -
Change In Other Current Assets $-47,177 $0 - -
Change In Payables And Accrued Expense $2,394,527 $1,854,714 $1,738,532 $754,147
Change In Accrued Expense $1,277,366 $56,131 $678,743 $-50,000
Change In Payable $1,117,161 $1,798,583 $1,059,789 $804,147
Change In Account Payable $1,117,161 $1,798,583 $1,059,789 $804,147
Change In Prepaid Assets $-196,535 $-123,627 $-24,774 $-87,926
Other Non Cash Items $3,362,551 $3,178,545 $11,327,295 $206,891
Stock Based Compensation $35,555,059 $0 $0 $1,291,909
Asset Impairment Charge $0 $703,796 $0 -
Depreciation Amortization Depletion $36,461 $245,945 $0 -
Depreciation And Amortization $36,461 $245,945 $0 -
Depreciation $36,461 $245,945 $0 -
Gain Loss On Investment Securities $689,543 - - -
Net Income From Continuing Operations $-62,146,210 $-11,898,464 $-14,921,065 $-3,046,757
Interest Paid Supplemental Data - - $0 $2,261
Change In Other Working Capital - - - $-50,000
Change In Receivables - - - $0
Changes In Account Receivables - - - $0
Fetched: 2026-06-15